Activated ERK1 and ERK2 S/T kinases phosphorylate and activate a variety of substrates, including p90 Ribosomal six kinase-1 (p90Rsk1) and this pathway has been implicated in cancer progression [1-3]. Here, MAPK1 is linked to cancer.